[Experience with ipriflavone therapy in postmenopausal osteoporosis].
The data of 55 patients treated with ipriflavone are discussed. The protocol of examination and treatment are introduced. At the 12-month follow-up visit BMI increased with 3-5% in the lumbal spine and in the femur neck. Significant decrease of pain was observed in 55% of the patients. The number of side effects were low. According to the data, ipriflavone treatment was effective and well tolerated in postmenopausal osteoporosis. This treatment can be performed in cases when hormonal replacement therapy is contraindicated.